Federal regulators are proposing to insert language in a prescription drug rule that officials in some states believe would help pharmaceutical companies fight off lawsuits.

The proposal comes amid a flurry of high-profile, state and federal pharmaceutical liability cases, including a mounting numbers of cases involving the painkiller Vioxx, made by Merck & Co.